• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Role of the dihydrofolate reductase DfrA (Rv2763c) in trimethoprim-sulfamethoxazole (co-trimoxazole) resistance in Mycobacterium tuberculosis.

作者信息

Köser Claudio U, Summers David K, Archer John A C

出版信息

Antimicrob Agents Chemother. 2010 Nov;54(11):4951-2; author reply 4952. doi: 10.1128/AAC.00876-10.

DOI:10.1128/AAC.00876-10
PMID:20947864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2976105/
Abstract
摘要

相似文献

1
Role of the dihydrofolate reductase DfrA (Rv2763c) in trimethoprim-sulfamethoxazole (co-trimoxazole) resistance in Mycobacterium tuberculosis.二氢叶酸还原酶DfrA（Rv2763c）在结核分枝杆菌对甲氧苄啶-磺胺甲恶唑（复方新诺明）耐药中的作用
Antimicrob Agents Chemother. 2010 Nov;54(11):4951-2; author reply 4952. doi: 10.1128/AAC.00876-10.
2
Role of mutations in dihydrofolate reductase DfrA (Rv2763c) and thymidylate synthase ThyA (Rv2764c) in Mycobacterium tuberculosis drug resistance.二氢叶酸还原酶DfrA（Rv2763c）和胸苷酸合成酶ThyA（Rv2764c）中的突变在结核分枝杆菌耐药性中的作用。
Antimicrob Agents Chemother. 2010 Oct;54(10):4522-3; author reply 5423-5. doi: 10.1128/AAC.00422-10.
3
Mechanisms of Resistance to Folate Pathway Inhibitors in : Deviation from the Norm.叶酸代谢途径抑制剂耐药机制：偏离常态。
mBio. 2017 Sep 5;8(5):e01357-17. doi: 10.1128/mBio.01357-17.
4
Resistance to trimethoprim-sulfamethoxazole and modifications in genes coding for dihydrofolate reductase and dihydropteroate synthase in European Streptococcus pneumoniae isolates.欧洲肺炎链球菌分离株对甲氧苄啶-磺胺甲恶唑的耐药性以及二氢叶酸还原酶和二氢蝶酸合酶编码基因的改变
J Antimicrob Chemother. 2001 Dec;48(6):935-6. doi: 10.1093/jac/48.6.935.
5
E84G mutation in dihydrofolate reductase from drug resistant strains of Mycobacterium tuberculosis (Mumbai, India) leads to increased interaction with Trimethoprim.来自结核分枝杆菌耐药菌株（印度孟买）的二氢叶酸还原酶中的E84G突变导致与甲氧苄啶的相互作用增加。
Int J Mycobacteriol. 2015 Jun;4(2):97-103. doi: 10.1016/j.ijmyco.2015.02.001. Epub 2015 Mar 13.
6
Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae.耐甲氧苄啶肺炎链球菌分离株二氢叶酸还原酶基因的突变
Antimicrob Agents Chemother. 1997 Nov;41(11):2406-13. doi: 10.1128/AAC.41.11.2406.
7
Mycobacterium tuberculosis dihydrofolate reductase is not a target relevant to the antitubercular activity of isoniazid.结核分枝杆菌二氢叶酸还原酶不是异烟肼抗结核活性的相关靶点。
Antimicrob Agents Chemother. 2010 Sep;54(9):3776-82. doi: 10.1128/AAC.00453-10. Epub 2010 Jun 21.
8
Pathogenic Nocardia cyriacigeorgica and Nocardia nova Evolve To Resist Trimethoprim-Sulfamethoxazole by both Expected and Unexpected Pathways.致病诺卡氏菌和新型诺卡氏菌通过预期和意外途径进化以抵抗甲氧苄啶-磺胺甲噁唑。
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00364-18. Print 2018 Jul.
9
The BpeEF-OprC efflux pump is responsible for widespread trimethoprim resistance in clinical and environmental Burkholderia pseudomallei isolates.BpeEF-OprC 外排泵是导致临床和环境中广泛出现的假单胞菌属类鼻疽伯克霍尔德菌对甲氧苄啶耐药的原因。
Antimicrob Agents Chemother. 2013 Sep;57(9):4381-6. doi: 10.1128/AAC.00660-13. Epub 2013 Jul 1.
10
Intra- and extracellular activities of trimethoprim-sulfamethoxazole against susceptible and multidrug-resistant Mycobacterium tuberculosis.甲氧苄啶-磺胺甲恶唑对敏感和耐多药结核分枝杆菌的细胞内和细胞外活性。
Antimicrob Agents Chemother. 2014 Dec;58(12):7557-9. doi: 10.1128/AAC.02995-14. Epub 2014 Sep 22.

引用本文的文献

1
The resistomes of Mycobacteroides abscessus complex and their possible acquisition from horizontal gene transfer.脓肿分枝杆菌复合体的耐药组及其可能通过水平基因转移获得。
BMC Genomics. 2022 Oct 20;23(1):715. doi: 10.1186/s12864-022-08941-7.
2
Structure based drug discovery for designing leads for the non-toxic metabolic targets in multi drug resistant Mycobacterium tuberculosis.基于结构的药物发现，用于设计多药耐药结核分枝杆菌无毒代谢靶标先导化合物。
J Transl Med. 2017 Dec 21;15(1):261. doi: 10.1186/s12967-017-1363-9.
3
Added value of whole-genome sequencing for management of highly drug-resistant TB.全基因组测序在耐多药结核病管理中的附加价值。
J Antimicrob Chemother. 2015 Apr;70(4):1198-202. doi: 10.1093/jac/dku508. Epub 2014 Dec 9.
4
Intra- and extracellular activities of trimethoprim-sulfamethoxazole against susceptible and multidrug-resistant Mycobacterium tuberculosis.甲氧苄啶-磺胺甲恶唑对敏感和耐多药结核分枝杆菌的细胞内和细胞外活性。
Antimicrob Agents Chemother. 2014 Dec;58(12):7557-9. doi: 10.1128/AAC.02995-14. Epub 2014 Sep 22.
5
Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance.结核分枝杆菌复合群内遗传多样性对新型抗生素的开发和耐药性诊断检测的重要性。
Antimicrob Agents Chemother. 2012 Dec;56(12):6080-7. doi: 10.1128/AAC.01641-12. Epub 2012 Sep 24.
6
The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis.磺胺甲恶唑、甲氧苄啶与异烟肼或利福平联合使用具有杀菌作用，并可防止结核分枝杆菌出现耐药性。
Antimicrob Agents Chemother. 2012 Oct;56(10):5142-8. doi: 10.1128/AAC.00832-12. Epub 2012 Jul 23.
7
Polymorphisms in isoniazid and prothionamide resistance genes of the Mycobacterium tuberculosis complex.结核分枝杆菌复合群中异烟肼和丙硫异烟胺耐药基因的多态性。
Antimicrob Agents Chemother. 2011 Sep;55(9):4408-11. doi: 10.1128/AAC.00555-11. Epub 2011 Jun 27.

本文引用的文献

1
[Reliability of Commercial Tests for Hepatitis C Virus].[丙型肝炎病毒商业检测的可靠性]
Rev Medica Hered. 2018 Jan-Mar;29(1):60-63. doi: 10.20453/rmh.v29i1.3265.
2
Impact of cotrimoxazole on carriage and antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-infected children in Zambia.赞比亚 HIV 感染儿童中复方新诺明对肺炎链球菌和流感嗜血杆菌定植及耐药性的影响。
Antimicrob Agents Chemother. 2010 Sep;54(9):3756-62. doi: 10.1128/AAC.01409-09. Epub 2010 Jun 28.
3
Mycobacterium tuberculosis dihydrofolate reductase is not a target relevant to the antitubercular activity of isoniazid.结核分枝杆菌二氢叶酸还原酶不是异烟肼抗结核活性的相关靶点。
Antimicrob Agents Chemother. 2010 Sep;54(9):3776-82. doi: 10.1128/AAC.00453-10. Epub 2010 Jun 21.
4
The HIV-associated tuberculosis epidemic--when will we act?HIV 相关结核病疫情——我们何时采取行动？
Lancet. 2010 May 29;375(9729):1906-19. doi: 10.1016/S0140-6736(10)60409-6. Epub 2010 May 18.
5
Mycobacterium tuberculosis and sulfamethoxazole susceptibility.结核分枝杆菌与磺胺甲恶唑敏感性
Antimicrob Agents Chemother. 2010 Jun;54(6):2748; author reply 2748-9. doi: 10.1128/AAC.00029-10.
6
Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV.复方磺胺甲噁唑预防用药和异烟肼预防治疗在 HIV 感染者中的实施。
Bull World Health Organ. 2010 Apr;88(4):253-9. doi: 10.2471/BLT.09.066522. Epub 2009 Oct 23.
7
Genotyping of genetically monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the limitations of current methodologies.对遗传上同质细菌的基因分型：结核分枝杆菌的 DNA 测序突出了当前方法学的局限性。
PLoS One. 2009 Nov 12;4(11):e7815. doi: 10.1371/journal.pone.0007815.
8
Reconsidering some approved antimicrobial agents for tuberculosis.重新审视一些已获批的抗结核抗菌药物。
Antimicrob Agents Chemother. 2009 Nov;53(11):4577-9. doi: 10.1128/AAC.00887-09. Epub 2009 Sep 8.
9
Tuberculosis and trimethoprim-sulfamethoxazole.结核病与甲氧苄啶-磺胺甲噁唑。
Antimicrob Agents Chemother. 2009 Nov;53(11):4789-93. doi: 10.1128/AAC.01658-08. Epub 2009 Jun 29.
10
M. tuberculosis Central Asian Strain 1 MDR isolates have more mutations in rpoB and katG genes compared with other genotypes.与其他基因型相比，结核分枝杆菌中亚1型多重耐药分离株的rpoB和katG基因有更多突变。
Scand J Infect Dis. 2009;41(1):37-44. doi: 10.1080/00365540802570519.